Why politics may get in the way of the public accepting a COVID-19 vaccine

The key to defeating the COVID-19 pandemic may have less to do with vaccine science and logistics and more to do with public trust. Week after week, actions by Trump administration appointees have raised suspicions that political motives rather than science are driving decision-making in the development of the vaccine.



a person wearing a mask: A shot is administered March 16 as part of a first-stage clinical trial of a potential vaccine for COVID-19 manufactured by Massachusetts-based Moderna Inc. (Ted S. Warren / Associated Press)


© Provided by The LA Times
A shot is administered March 16 as part of a first-stage clinical trial of a potential vaccine for COVID-19 manufactured by Massachusetts-based Moderna Inc. (Ted S. Warren / Associated Press)

Events like these have shaken my faith — and the faith of many others — in two of the country’s most revered scientific institutions, the Centers for Disease Control and Prevention, which collects and analyzes healthcare data, and the Food and Drug Administration, which approves diagnostic tests and treatments.

As a longtime clinical scientist at the National Institutes of Health, I worked closely

Read More

The COVID-19 Vaccine Protest Movement Is Far Ahead of the Vaccine Itself

Protesters in red jumpsuits with chains around  their necks wear masks of British Exchequer Rishi Sunak and Bill Gates in Trafalgar Square, London.

Demonstrators dressed as Chancellor of the Exchequer Rishi Sunak and Bill Gates in prison uniforms take part in Unite for Freedom rally in Trafalgar Square to protest against the restrictions imposed by the Government to control the spread of coronavirus, September 26, 2020. Photo via Getty Images.

“Today Berlin is again the front against totalitarianism,” Robert F. Kennedy crowed on a warm and surreal August day in Berlin. The longtime environmental activist turned vaccine critic regarded a crowd of around 38,000 —which he’d previously claimed would number a million or more—and regaled them with dubious claims. Governments “love” pandemics, he assured the crowd, because they’re used to impose tools of global control “that the populace would otherwise never accept.” The COVID-19 pandemic, he claimed, was being used as a cover to get the populace to accept both 5G technology, which Kennedy regards as a tool of the nefarious global surveillance

Read More

Australian Treasurer Says Budget Assumes Virus Vaccine Next Year

(Bloomberg) —



a row of computer equipment on a table: Glass vials move along a conveyor at the Gerresheimer AG medical glassware factory in Buende, Germany, on Tuesday, Aug. 11, 2020. Gerresheimer has built up capacity and most of its factories are operating around the clock as the company holds talks with pharma companies, working on a coronavirus vaccine.


© Bloomberg
Glass vials move along a conveyor at the Gerresheimer AG medical glassware factory in Buende, Germany, on Tuesday, Aug. 11, 2020. Gerresheimer has built up capacity and most of its factories are operating around the clock as the company holds talks with pharma companies, working on a coronavirus vaccine.

Australia’s budget forecasts will assume a coronavirus vaccine will be developed in the next year, Treasurer Josh Frydenberg says.

“The budget takes into account the possibility that is the case,” Frydenberg told Sky News Australia in a segment from an interview to be broadcast Monday”. “We have factored in those issues related to the vaccine and those will be available on budget night.”

Assuming a vaccine is available in 2021 will be a positive for the economic outlook, as it may signal a return to international travel and foreign tourist spending. Frydenberg is set to use

Read More

But many experts surveyed also believe vaccine development will take place at an accelerated rate — ScienceDaily

Experts working in the field of vaccine development tend to believe that an effective vaccine is not likely to be available for the general public before the fall of 2021. In a paper published this week in the Journal of General Internal Medicine, a McGill-led team published the results of a recent survey of 28 experts working in vaccinology.

The survey was carried out in late June 2020. The majority of those surveyed were mostly Canadian or American academics with an average of 25 years of experience working in the field.

“Experts in our survey offered forecasts on vaccine development that were generally less optimistic than the timeline of early 2021 offered by US public officials. In general they seem to believe that a publicly available vaccine next summer is the best-case scenario with the possibility that it may take until 2022,” said Jonathan Kimmelman, a James McGill professor

Read More

Providing new technologies for vaccine development

Providing new technologies for vaccine development
Credit: Design_Cells/Shutterstock

Vaccines, which help the body recognize infectious microorganisms and stage a stronger and faster response, are made up of proteins that are specific to each type of microorganism. In the case of a virus, viral proteins—or antigens—can sometimes be attached to a protein scaffold to help mimic the shape of the virus and elicit a stronger immune response. Using scaffolds to approximate the natural configuration of the antigen is an emerging approach to vaccine design.

A team of scientists led by David Baker at the University of Washington developed a method to design artificial proteins to serve as a framework for the viral antigens. Their study was published recently in the journal eLife. Berkeley Lab scientists collected data at the Advanced Light Source to visualize the atomic structure and determine the dynamics of the designed scaffolds.

“When bound, the scaffolds assume predicted geometries, which more closely approximate

Read More

The surprising future of vaccine technology

LOU REESE: The largest gains in human longevity ever are debatably attributed to vaccine technology.

The antibiotic revolution was very important, but vaccine technology is currently over 6.2 billion people in the world have been vaccinated right now. These are the most widely distributed medications and solutions that have ever been brought to mankind. And the consequence was that we really dramatically improved our quality of life and our longevity. We gave people better, healthier, longer lives.

LARRY BRILLIANT: Vaccines are the best thing science has ever given us. It saved hundreds of millions of children’s lives. It eradicated smallpox. It has reduced the population explosion. I know that’s pretty paradoxical but as long as there are vaccines children will not die as they did when I was in India. There were places that 50 percent of kids died before the age of five. When that happens parents have many

Read More

Vaccine makers using new mRNA vaccine technology to beat coronavirus



a person holding a microphone: KFYR


© Provided by Minot-Bsmrck-Dcknsn(Wlstn) KFYR-TV
KFYR

BISMARCK, N.D. (KFYR) – Eliminating a novel virus might require a novel approach. Vaccine makers Moderna and Pfizer are using messenger RNA, or mRNA, to produce their vaccines.

This new technology has never before received regulatory approval.

If the mRNA vaccines make it to the general public, doctors say they will look indistinguishable from traditional vaccines.

However, they work in a different way. Instead of injecting a dead or weakened version of the virus into the patient’s body, doctors will be injecting the genetic information to produce the antigen, or antibodies, to fight the disease.

Companies are developing mRNA vaccines to combat coronavirus, and people seem to be on the fence about the new method.

“I honestly don’t know. I guess I would probably wait for a while and see how things go before I would get the vaccine,” said Dickinson Resident Darcy

Read More

COVID-19 Recovery Analysis: Dengue Vaccine Market | Rapid Growth in Disease Prevalence to Boost the Market Growth

Technavio has been monitoring the dengue vaccine market and it is poised to grow by $ 630.65 million during 2020-2024, progressing at a CAGR of over 26% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200925005218/en/

Technavio has announced its latest market research report titled Global Dengue Vaccine Market 2020-2024 (Graphic: Business Wire)

Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavio’s in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. We offer $1000 worth of FREE customization

Read More

AstraZeneca coronavirus vaccine trials remains on hold in the U.S., HHS chief Azar says

AstraZeneca’s late-stage coronavirus vaccine trial in the U.S. remains on hold as federal investigators seek “answers to important questions” over its safety for patients, Health and Human Services Secretary Alex Azar told CNBC on Wednesday.  

Global clinical trials for AstraZeneca’s Covid-19 vaccine, called AZD1222, were placed on hold Sept. 6 after one of the participants in the U.K. reported a serious adverse reaction. Following an investigation, AstraZeneca said on Sept. 12 that it had resumed trials in the U.K., though the U.S. trial has since remained on hold. 

“Look at the AstraZeneca program, phase three clinical trial, a lot of hope. Single serious adverse event report in the United Kingdom, global shutdown and hold of the clinical trials,” Azar told CNBC’s “Squawk Box” in defense of the Trump administration’s quick development of a Covid-19 vaccine amid safety concerns. 

“Still on hold here in the United States as the (U.S. Food

Read More

Daily smartphone tracking planned for first recipients of COVID-19 vaccine – U.S.

Daily smartphone tracking planned for first recipients of COVID-19 vaccine


Stars and Stripes is making stories on the coronavirus pandemic available free of charge. See other free reports here. Sign up for our daily coronavirus newsletter here. Please support our journalism with a subscription.


WASHINGTON (Tribune News Service) — Americans that get the first COVID-19 vaccines will be closely monitored by the U.S. Centers for Disease Control and Prevention through daily text messages and emails, according to a federal advisory group.


Essential workers who are expected to be the first recipients will get daily text messages on their smartphones asking about side effects in the first week after they get the shot, and then they’ll be contacted weekly for six weeks, said Tom Shimabukuro, a CDC immunization expert, at a meeting of the CDC’s Advisory Committee on Immunization Practices. Those workers could total about

Read More